Research may change traditional heart attacks treatment guidelines. Heart attacks are medical emergencies in which the blood supply that normally nourishes the heart with oxygen is blocked. Now, the latest study from Sweden has discovered new ways that will change the existing face of the treatment.
Antibodies, or immunoglobulins (Ig), are proteins produced mainly by plasma cells that are often used by the immune system to fight potentially harmful foreign bodies.
Scientists from the Karolinska Institutet in Solna, Sweden, claims that several antibodies are also present inside the bodies of those who have had a heart attack. These are known as antiphospholipid antibodies (aPLs) which can increase a person’s risk of blood clots.
In the new study, the researchers followed 800 people admitted as patients at 17 Swedish hospitals. These patients were admitted to experiencing a heart attack for the first time. In addition, the investigators also included a control group of healthy participants in the study.
After analyzing the data, the researchers found the antiphospholipid antibodies (aPLs) in 11 percent of the patients’ bodies who had experienced heart attacks. The aPLs was reached to both cardiolipin and beta-2-glycoprotein-I and was also 10 times more people compared to the control group.
“I’ve long been convinced that the antibodies are more common than we think and have now been able to analyze their presence in a large patient material,” explains study author Prof. Elisabet Svenungsson.
“This would change the prevailing guidelines for the investigation and treatment of heart attacks.”